Good day, ladies and gentlemen, and welcome to the Third Quarter 2017 AMETEK, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. I would now like to turn the call over to Kevin Coleman, Vice President, Investor Relations.

Thank you, Andrew. Good morning, and thank you for joining us for AMETEK's third quarter earnings conference call. With me this morning are Dave Zapico, Chairman and Chief Executive Officer; and Bill Burke, Executive Vice President and Chief Financial Officer. AMETEK's third quarter results were released earlier this morning and are available electronically on market systems and on our website in the Investors section of ametek.com. This call is also being webcasted, and can be accessed on our website. The webcast will be archived and made available on our site later today. Before we get started, I want to remind you that any statements made by AMETEK during the call that are not historical in nature are to be considered forward-looking statements. As such, these statements are subject to change based on various risk factors and uncertainties that may cause actual results to differ significantly from expectations. A detailed discussion of the risk and uncertainties that may affect our future results is contained in AMETEK's filings with the Securities and Exchange Commission. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements. I will also refer to you to the Investors section of ametek.com for a reconciliation of any non-GAAP financial measures used during this conference call. Please note that any references on this call to full year 2016 financial results will be on an adjusted basis, excluding the fourth quarter of 2016 adjustments. We'll begin today's call with prepared remarks by Dave and Bill, and then, open it up for your questions. I'll now turn the call over to Dave.

Thank you, Kevin, and good morning, everyone. We are very pleased with our performance in the third quarter. The AMETEK business model continues to deliver exceptional results, with another outstanding high-quality quarter. We generated a record level of sales, with both strong organic sales growth and solid contributions from our recent acquisitions. We delivered excellent operating performance which drove a record level of diluted earnings per share and we generated significant level of operating cash flow with impressive free cash flow conversion, which speaks of the high-quality nature of AMETEK's performance. As a result, we are again raising our full-year 2017 guidance across all key metrics. Now, on to the financial and business highlights for the quarter. AMETEK's sales in the third quarter were a record $1.08 billion, up 15% compared to the third quarter of 2016. Organic sales were up 7%. Acquisitions added 7%, and foreign currency was a one-point benefit. We are very encouraged by the continued strong level of organic sales growth. It remains broad based and reflects the strength of our underlying niche businesses. In addition to the strong sales growth, we continued to see excellent growth in orders. Overall orders were up 16% in the quarter, while organic orders were up 9%. This level of organic growth drove our record backlog at nearly $1.4 billion. Operating income in the quarter was $232.8 million, up 16% from the same quarter of 2016. Operating income margins were 21.5%, up 20 basis points compared to the third quarter of last year. Excluding the dilutive impact on margins of recent acquisitions, operating income margins in the quarter were 22%, up 70 basis points versus the same period in 2016. Third quarter diluted earnings per share were a record $0.66, an 18% increase compared to last year's third quarter of…

Thank you, Dave. As Dave mentioned, our businesses continue to perform very well, generating record results during the third quarter. Let me provide some additional financial highlights. In the third quarter, core selling expenses were up in line with core sales growth. General and administrative expense in the third quarter were up $2.7 million over the prior year, due largely to higher compensation expense. The effective tax rate for the third quarter was 24.9%, in line with last year's third quarter rate of 25%. For 2017, we now expect our tax rate to be between 26% and 26.5%. As we stated in the past, actual quarterly tax rates can differ dramatically either positively or negatively from this full-year rate. Working capital, defined as receivables plus inventory less payables, was excellent at 17.9% of sales in the third quarter, down from 20.8% in the same period of 2016. Capital expenditures were $18 million for the quarter, and $46 million through the first nine months of 2017. We expect full year capital expenditures to be approximately $80 million. Depreciation and amortization for the quarter was $45 million. For the full year, we expect depreciation and amortization to be approximately $180 million. Our businesses continue to generate excellent cash flow. Third quarter operating cash flow was $239 million, a 41% increase compared to the third quarter of 2016. Free cash flow in the quarter was $221 million, an outstanding 144% of net income. For the full year, excluding the $50 million pension contribution we made in the first quarter, we expect free cash flow to be approximately 125% of net income. Our primary use of this strong cash generation is to support strategic acquisitions. As Dave mentioned, we've been very active on this front in 2017, deploying approximately $520 million on the acquisitions of Rauland and MOCON. Total debt at September 30 was $2.43 billion, up from $2.34 billion at the end of 2016. Offsetting this debt is cash and cash equivalents of $736 million, resulting in a net debt to capital ratio at September 30 of 31%. At quarter end, we had approximately $1.8 billion of cash in existing credit facilities to support our growth initiatives. To summarize, the performance from our businesses during the quarter was outstanding and provided high quality of earnings. We look forward to closing out a strong year, and remain well positioned to support our growth initiatives with our strong balance sheet and excellent cash flow. Kevin?

Great. Thank you, Bill. Andrew, we'd like to open the line for questions, please.

Certainly. Our first question comes from the line of Andrew Obin with Bank of America Merrill Lynch. Your line is now open.

Good morning, guys. Great quarter.

Thank you, Andrew.

Now, I will ask a question. If I look at your operating leverage back in sort of 2012, 2013, 2014 period, it does seem it was a tad higher versus what we're getting right now. Can you just talk about specific challenges of coming out this prolonged downturn and just how much costs you need to add and whether we can get back to the old operating leverage or this is the kind of level we should be thinking as new normal? Thank you.

Sure, Andrew. We think we had a great quarter margin wise. We were 21.5%, up 20 basis points. But excluding acquisitions, as I said in the prepared remarks, they were actually 22%, up 70 basis points. And if you go to the group lines, the EIG and EMG, ex acquisitions, were actually up 100 basis points in each group. And we saw incrementals, core incrementals in Q3 were up 39% on the incremental volume. So, we're very pleased with the results and we believe it's a good thing for our shareholders when AMETEK acquires lower-margin businesses. And what you're seeing is the Rauland and MOCON, when we acquired them, they were low to mid-teens EBITDA businesses. And AMETEK is obviously much more profitable. So, we improve the margins of those businesses substantially and they may be dilutive to margins for the short-term. But, ends up driving tremendous value creation in the long run and excellent returns on capital. So, we're very pleased with the performance of the strategy and we think it's endorsed with what we're trying to do with the business.

39%, nothing to sneeze at. Another question, can you just talk about, Dave, since you've taken over, what are the changes that you're implementing? We're sort of hearing about sort of a more structured approach to internal business systems. What can you share about what's happening inside AMETEK, culture wise?

Andrew, I've been with the company for 27 years and I was part of the culture of the past and part of the culture going forward, and really, the culture hasn't changed. I mean, the two areas that we've talked about, we've definitely put a larger emphasis on our organic growth and we have a structured approach to that, and we made it part of our operational excellence program and we're really getting traction with that organic growth, and the tools that we're adding to our toolkit to help our businesses understand the opportunity. And then, the second issue is related to the size and scale of the business. We want to double the earnings of the company over the next five years. So, we increased our acquisition pipeline of businesses a little bit larger, $200 million to $400 million in revenue. Prior to that time, they weren't in the pipeline of deals. So, they're working through the deal pipeline and we're looking at those bigger deals and we think we can add the same kind of value to them. But, it's the same company. The strategy is flexible enough to tweak it when it's needed. But, we feel really confident we're on the right track and headed in the right direction for the next five years.

Terrific. Thank you so much.

Thank you.

And our next question comes from the line of Scott Graham with BMO Capital Markets. Your line is now open.

Good morning, Dave, Bill, Kevin. How are you?

Good morning, Scott.

I was wondering if you wouldn't go through your typical by-business...

Sub-segment sure (19:56).

Yeah. But even, if I may, before that, could you talk about the orders as the quarter progressed? And obviously, I'm not talking about dollars because of seasonality, but on a year-over-year percentage change basis. Because your second half of last year starts to show some more stability in orders. And just kind of wondering what that looked like as each month passed? And now with October done, if you can maybe comment there, as well?

Yeah. Our orders for the quarter organically were up 9%. So, we had a very strong quarter in orders and it was broad based across end markets and geographies, and it followed a typical pattern. So, we started the quarter a little bit lower and we finished really strongly. So, the orders strengthened through the quarter. And that answers that question. I'll get into the sub-segments. Go across around the sub-segments of AMETEK. I'll start with our overall Aerospace business. Sales for overall Aerospace were up low-single digits in the quarter. Similar to last year, we saw strong growth across – similar to last quarter, we saw strong growth across our military business. Our military business has really picked up. We also saw solid growth across our business and regional jet business due to a ramp up in shipments and support of new program wins. And for all of 2017, we continue to expect our Aerospace business to be up low to mid-single digits with growth expected across each of our market segments. In addition to the solid growth this year, the Aerospace business is a long-term business and you have to win new programs. And our Aerospace teams continue to have excellent success in delivering new long-term program wins across a wide range of platforms. Year-to-date, our teams have already secured over $300 million in life of program awards across a range of commercial, business jet, and military platforms. Next, I'll talk about process. Our process business has had an excellent third quarter, with overall sales up 20%, driven by contributions from the acquisitions of Rauland and MOCON and by strong mid-single digit organic growth. The organic sales growth was broad based across our process businesses. And we saw excellent growth across our ultra-precision technologies, our UPT business, especially…

That'll do it. Thank you.

Thank you, Scott.

And our next question comes from the line of Brett Linzey with Vertical Research. Your line is now open.

Hi, good morning, all.

Good morning, Brett.

Just want to come back to the growth initiatives. Obviously, a lot of traction there on the channel development and some of the measures you're taking internally. I guess, if you were to look at the order rate of 9% in the quarter, are you able to identify or unbundle that rate between what's being driven by the market and what share gain and some of the opportunities that you think you're winning based on some of these initiatives?

Yes, we are definitely seeing broad based improvement across our end markets and we're also seeing improved geographical strength throughout the world. But, with 7% organic growth, we're clearly win share also, both in Q3 and as you see in the first nine months of the year. And we're certainly seeing tangible success from some of the organic growth initiatives that you mentioned, and we also continue to see great success from our new product development efforts driving market share gains. But it's very difficult to dissect those in our niche businesses. And so, we're definitely growing share, and if I point you to some businesses where I saw excellent performance, is our PMC business. The automation market is about 10% of sales for AMETEK. And participation in this market is the result of some acquisitions that we based around our core motor technology, and it's resulted in the acquisitions of Dunkermotoren and Haydon Kerk. And really those businesses, working in unison, have perfected the art of delivering custom automation subassemblies to customers and they're seeing tremendous growth and the growing share in a good market. We're also growing share in our Ultra Precision Technologies business. But in general, across the board, we're motivated, we're winning share, and we're also benefiting from improvements in end markets and improvements in geographies, and it's very difficult to break those out.

Understood. And then, just back to EIG operating margins, obviously some dilutive pressure from the two deals in 2017. But, I guess, as you normalize, or you think about the construct into 2018, what was the headwind this year? How much more runway do you have over the next 12 months to improve the operational performance in those businesses? And I guess, I'm trying to get at, what's sort of a good placeholder for EIG margins into 2018 as these integrations kind of run their course?

Right. I understand the question. As we always do, we'll provide our guidance for 2018 when we release our fourth quarter earnings in late January. And our businesses in both EIG and EMG are going through their detailed budget work, and we'll be meeting with each business this month to review those plans for next year. So, I'm really not in a position to comment on our expectations for 2018. But I will say that we've stated externally that we think there's margin expansion opportunities for the company. And the number that we've used, as far as the eye can see is 30 basis points to 40 basis points. And we get to that number by taking the high contribution margins of our business, of 40-plus percent, 35% contribution margins and adding to that our pricing power, and adding to that our tremendous operating capability. So, as we sit here and we look out long term, we'll certainly be expanding margins, but I don't want to comment specifically on a group or a business because we haven't done the work yet.

Okay. And then, just one follow-up. You said 39% core incrementals. Presumably, most of the pressure, sort of one-time pressure would be in EIG. Electromechanical incrementals were kind of 27%. So, implicitly, much higher in EIG on a core basis. What were they, on a core basis, if you remove some of the deal noise in EIG?

Yeah, it was over 50% on a core basis. I think it was 57%. So, you're right on that.

Okay, great. Thanks, guys.

Thanks, Brett.

And our next question comes from the line of Matt Summerville with Alembic Global Advisors. Your line is now open.

Thank you. Just a quick one in terms of where you were in the quarter on pricing versus raw material input costs, and whether or not you have any sort of concern over inflationary pressures heading into 2018, perhaps more so than you were heading into 2017?

Sure, Matt. Pricing actually improved in Q3 versus the first half of the year for us. So, we achieved 1.3% across our entire portfolio, and total inflation was about 1%. And it was very balanced across our portfolio, with similar results in all our different businesses. So, we are very pleased with that. And as you know, some other industrial companies have not been able to offset inflationary costs with increased pricing. So we were concerned with this trend and made sure all our business leaders were aware of it, and we're very pleased with the results. The results speak to the differentiated aspect and nature of AMETEK's product portfolio and our leadership position in the niche markets that we're in. And, as I said before in the prior quarter, what you see generally in 2016, the customers will migrate to – we have a good, better, best pricing marketing philosophy within the AMETEK portfolio. So, often, when times are tough and customers don't have a lot of capital to spend, they'll buy our good products. And as the markets tend to improve, customers will buy a fully-featured product, that are maybe the best. And we'll see pricing expand with that. So, we are pleased to see 1.3 points of price in the quarter and we feel good for fourth quarter that kind of performance will be able to continue.

And then, just a follow-up on backlog. You continued, I believe so, at least, continued to build backlog throughout the year. What has been the key sort of either business or end market contributors to that build? And do you expect further expansion in Q4? Thank you.

Yeah. Our backlog was a record at $1.4 billion and it was broad based. I mean, we had positive book-to-bill in EIG and EMG. So, as we had said in prior quarters, with some of our longer-cycle businesses, they're not going to necessarily ship in the next quarter or the current quarter. They're going to be out there in the backlog. So, that's what you see happening. You see our longer cycle businesses strengthening.

Got it. Thanks, David.

Sure.

And our next question comes from the line of Christopher Glynn with Oppenheimer. Your line is now open. Christopher Glynn - Oppenheimer & Co., Inc.: Thanks, good morning.

Hi, Chris. Christopher Glynn - Oppenheimer & Co., Inc.: Hey, just wanted to – you talked about areas where you're gaining share. Just wanted to see if you could draw a distinction between gaining share or actually creating market size with some of your applications.

Yeah. I mean, creating markets is something that we're doing with some of our technologies, like our – in our Materials Analysis business. And we're doing adjacency work there and adjacency work on our UPT business. And those adjacency works were often taking core technologies and combining it with other technologies into new markets and creating some markets. Our atom probe for our Materials Analysis division will be that kind of business, where there's really no competition, because we've got the only person that manufactures atom probes. And so, we're creating a market there. And creating a market could take time, and there's a lot of missionary work done on the expenses. We're doing some missionary work like that with our Creaform business, also, with our – and our UPT business with some of the 3D metrology. So, that's happening. But, what you really see is, in general, good markets and share gains adding to 7% organic growth. Christopher Glynn - Oppenheimer & Co., Inc.: Okay, thanks. And just in terms of the M&A pipeline, I think some areas like metrology and power quality, you've done a fair amount of consolidation already. What platforms you're currently seeing as particularly attractive in terms of the fragmentation out there and ripeness for you to step up the consolidation?

Right. Well, we have a dedicated team of about 10 M&A professionals who work closely with our businesses to identify strategic acquisitions and we have each of our business units develops an acquisition strategy. So, we have a lot of people working on a lot of things across a broad set of opportunities which we can identify, find good fits for AMETEK and remain disciplined in our return metrics. So, we need a big pipeline. We've got a lot of people working on it and we're searching for deals in a lot of areas. Christopher Glynn - Oppenheimer & Co., Inc.: Okay. Thanks for the color.

Thanks, Chris.

And our next question comes from the line of Nigel Coe with Morgan Stanley. Your line is now open. Sawyer C. Rice - Morgan Stanley & Co. LLC: Hi, good morning. You've actually got Sawyer Rice on here for Nigel. Maybe just, firs, a high level question on EPS reporting. We've seen some news from other companies around the industry, on shifting to a cash EPS or an EPS that excludes the amortization. Just wanted to know if you guys have had any – if that's something you guys have looked at or any thoughts on that metric there.

Yeah. Being an acquisitive company, we certainly would have a benefit if we excluded the amortization. But we reported – we're a GAAP company and at this time, we decided to not to do that at this point. We've been talking to our investor base about it. Even within the same shops, there's a bit of an argument within our investor base if we do it or not, so we're listening to it. And we certainly don't want to put ourselves at a disadvantage, but we report GAAP numbers and we haven't made a decision to do cash EPS reporting. We've reported the amortization, so it's out there and it can be calculated and figured out. But, we have no plans to do it at this time. That's probably the best way to state it. Sawyer C. Rice - Morgan Stanley & Co. LLC: Great. And then, maybe just one more, if I could squeeze it in here. On the EMIP backlog, just any color on the visibility you have in that business? And then, again, maybe some color on how we should think about orders phasing through 4Q and into 2018, in terms of conversion and sales. Thanks.

Sure. Yeah. In Q3, our EMIP business showed a continuing positive sequential trend. Sales were strong. Orders were also strong in the quarter, a bit better than the EMG average for organic sales. And for the year, for EMG – for EMIP, we're projecting mid to high-single-digit organic growth in line with the EMG average. So, very pleased with what's happening in that business. Very pleased with the sequential growth and it feels like our customers are back to normal and we're executing well. Sawyer C. Rice - Morgan Stanley & Co. LLC: Thanks.

Sure.

And our next question comes from the line of Robert McCarthy with Stifel. Your line is now open. Robert Paul McCarthy - Stifel, Nicolaus & Co., Inc.: Thanks. Congratulations, guys, on a strong quarter.

Thank you, Robert. Robert Paul McCarthy - Stifel, Nicolaus & Co., Inc.: I guess, dovetailing some of the other questions that have come on about margins, maybe you could give us a state of play for your end markets around specialty metals and oil and gas, and obviously it relates to certain divisions as well. But, how has been the incremental margin performance there? Has it been in line? Because, I think the previous expectation, sort of (36:46) was probably in the 40% to 50% range? Have we been seeing it there? Was it a major incremental driver for your incremental margin strength at EMG? And then, how do we think about in the context of these end markets whether we've already seen the bolus of kind of the rebound or is that more on the common fourth quarter and going into 2018?

Yeah. I mean, we're continuing to see our orders strong and there was broad-based improvement. So, orders were ahead of sales in a lot of our markets and a lot of our regions, so we're bullish about that. And our incremental margins were 39%. And with the contribution of the margin to the business is about 40%. So we think we're performing at a very strong level. And with the pricing power added to that, that's how we ended up with the EIG and EMG core margins at the group line, up 100 basis points. So, we're really pleased with – when you get under the hood, the margins are doing great and we look at it, even in the financial statements, with the acquisitions are doing very great. So, we're very pleased with our margin performance and we're very pleased with some of the pricing power we saw in the quarter. Robert Paul McCarthy - Stifel, Nicolaus & Co., Inc.: I guess – but the spirit of the question is maybe drilling into the specific end markets around oil and gas and specialty metals to see what was the relative mix in those areas and whether that mix is going to be on the come, have we seen it? Kind of, what's the timing of that kind of incremental strong mix?

Yeah, the one point with metals, there is a dynamic there with metals inflation. So, as metals inflation increases, we pass that through to our customers. So, when you look at the EMG organic sales rate of 11%, about a point of that was from metals inflation. So, if you want incremental or contribution margin, it will be on a lower sales number. So, that may be what you're asking a question about. And in terms of EIG, we're really seeing, in the oil and gas business, the upstream market is coming back very strong. We're seeing high-single-digit growth in the upstream and low-single-digit growth in the downstream. And we're also differentiated in niches, we didn't really give up much price in the downturn. So, we've got really strong pricing in oil and gas, and those markets are improving and it's a high contribution margin business and we're optimistic about the future. Robert Paul McCarthy - Stifel, Nicolaus & Co., Inc.: Well, it sounds, from Brett Linzie's comments – questioning, obviously, the EIG margins were kind of in the high-50s on a core basis. And then, EMG was kind of in the high-20s. So, that speaks to that dynamic you're talking about. So, I think that's an important nuance. The other thing ...

So, to be specific, EIG was 57% core incremental and EMG was 33%. Robert Paul McCarthy - Stifel, Nicolaus & Co., Inc.: Math has never been my strong suit. And then, finally, just on size decile, is there – do you think there's a strategic imperative here for the company, just given how long it takes to do a deal, the fixed cost and association with specing deals – getting done deals over the goal line, et cetera, et cetera. Could we see larger deals here given your fire power? How should we think about kind of the odds that your pipeline is maybe more shaped towards something larger?

Well, bigger deals are working in the pipeline. And you may see us announce a bigger deal every couple of years. But clearly, the core acquisition, the thing that AMETEK is really good at, is buying businesses in that $50 million to $150 million range, and that is the predominant acquisitions that you're going to see from us going forward. Our M&A team is setup to process four to six deals of these simultaneously, and we're out looking at a lot of things. Our pipeline remains active. Our pipeline is very active. We're busy, and we're excited about the quality and the breadth of our pipeline. And you can't ever predict when something's going to transact in the short term, but we don't feel any need to stretch and do a bigger deal. We think there's plenty of opportunities in typical size deals, but at the same time, we're starting to look at slightly larger deals. They are by no means mergers of equals or anything like that. These are $200 million to $300 million revenue businesses, but we think we can add a lot of value. But, I would say that the predominant acquisition will be those $100 million deals that we create a lot of value with going forward. Robert Paul McCarthy - Stifel, Nicolaus & Co., Inc.: Thanks for your time.

Thank you.

And our next question comes from the line of Allison Poliniak with Wells Fargo. Your line is now open.

Hi, guys, good morning.

Good morning, Allison.

Dave, could you talk about R&D, 5% of sales today? Any changes to where you're eyeing that R&D? Obviously, there's some more technical aspects of your portfolio. And I guess, is that an appropriate amount, or should we be increasing it going forward? Any thoughts there?

Yeah. I think the 5% is appropriate. And we've been very consistent over a long period of time, and the R&D was increased about 10% this year. So, healthy increase and we think we're getting a great return on that. And as you know, the way we manage that, our individual business units put together an R&D plan, those individual businesses will present their plans during their budgets and during their strat plans, and we'll critique them. But they're driving where they're spending their R&D. Certainly, with the higher technology nature and with the larger size of EIG, we spend a bit more on EIG than EMG, but we've been a consistent spender over the long-term and we're really happy with what's happening. We have up-to-date fresh products and we're winning share. So, we're very pleased with our R&D efforts. And I can just also add that over the past few years, we've added a tremendous capability in India. We have about 110 engineers over there that are augmenting our product development capability. And in our niche markets, we have some of the rock stars of the industry, in terms of our engineering capability with people that really know the products and the applications and take the technology forward. So, we have a great niche business of great technologies and we think we're spending appropriately.

Great. And then, just going back to the M&A pipeline, you talked about it being active, as the industrial economy recovers. Has there been any, I guess, push-back, changes to multiples? Any different color that you've been seeing there?

Yeah, sure. I mean, the current environment, it's very similar to what we've been experiencing recently. And pricing is elevated, there's no doubt about that. There's plenty of cash chasing deals. Despite this, we've been successful in deploying our free cash flow on acquisitions that will enhance the value of the company. So, we are really parsing a very robust pipeline to find the deals where we can remain disciplined in our return metrics. And we'll select the deals and we'll do the deals that – and we're focused on return on capital when we do a deal. So, we have $1.8 billion of fire power and really optimistic with what I see in the pipeline.

Great. Thank you.

Sure. Thanks.

And our next question comes from the line of Deane Dray with RBC Capital Markets. Your line is now open.

Hi, good morning. This is Jeff Reive on for Deane Dray. Maybe to continue with some of the M&A multiple. So, given the multiples are fairly high, are you guys making any considerations for portfolio pruning actions?

We ended our strategic planning process in the first half of the year, and we're very comfortable with our portfolio at this time. Our strategy is to focus on a broad, diverse set of niche markets, and we look to grow organically and through acquisitions in these niches. We don't want to become overexposed to any single market or any single customer. And we've weathered a bit of a downturn over the past couple of years, and all of our businesses have a bright future looking out the next two or three years. So, right now, that's our position. And certainly, we look at it at least annually, and those decisions can change. But, right now, we're very comfortable with our entire portfolio.

Great. And just one more. I know you're not giving any 2018 guidance, but could you provide some qualitative, maybe broader macro commentary for your setup into 2018?

Sure. I mean, we feel good about our markets. We're obviously very happy with the performance we have. Our execution is excellent, and we expect our execution to continue. But, I want to hear from our teams before we put any numbers out there for 2018.

Okay. Great. Thank you.

Thank you.

And our next question comes from the line of Brett Kearney (45:59) with Gabelli & Company. Your line is now open.

Hi, guys. Thanks for taking my question.

Hi, Brett (46:07).

I was just wondering if you can talk at all about the recent additions and, I guess, promotions you've had within the executive team, and any additional hires kind of contemplated there in order to achieve your growth objectives?

There is a couple of recent promotions – we're in the finance world. So, I'll let Bill talk about them.

Yeah. We have added Treasurer to AMETEK, his name is Dalip Puri. He's been Treasurer with several other large companies prior to joining AMETEK. So, we're happy to have him come along and augment the team there. He's got a really strong background in treasury, and we're pleased to include him as a part of the team. And then, the second addition was Brian Nash, who we promoted from our Power Systems and Instruments division as our VP of Operational Finance. And that's as we grow as a company, we want to make sure that we've got an adequate group of folks here in corporate to support our businesses, and really to help, as we get larger, to drive the AMETEK culture through the acquisitions and make sure that we maintain the strong disciplines that we've had over a long number of years. And promoting one of our best divisional folk up into a corporate role is great, and then, we'll back-fill from there. So, very pleased with the strengthening of the corporate finance team over the course of the last six to eight months.

Great. Thank you, guys.

Thank you.

And our next question comes from the line of Joe Giordano with Cowen. Your line is now open. Joseph Giordano - Cowen & Co. LLC: Hey, guys. Good morning. I know we're not going to get 2018 guidance here, but just – I want to kind of put the EMIP business into the appropriate context with metal prices up and aircraft build rates expected to ramp next year. So, can you kind of maybe frame out a scenario as to how that business enters the year? I mean, could we be looking at kind of like a material move in that segment of EMIP next year, particularly some of the specialty metals stuff and the connectors?

Yeah, I see – with EMIP, we're seeing in 2016, there was a financial problem in the metals market and we were really well positioned with niche products. And we told you at that time that the end markets were good, but the metals market in between us and our end customers were poor. So, what you really saw was that market in some distress. And what you really see now with the year, mid to high-single digit growth with our EMIP business is really a reflection of that improvement. So, we think we're at a level now that we're performing very well at and we're very pleased with the EMIP. Joseph Giordano - Cowen & Co. LLC: It probably wouldn't be insane to think that that could even accelerate further as the build rates go higher, is that fair?

I'm not going to comment on 2018, Joe. Joseph Giordano - Cowen & Co. LLC: All right. Fair enough. Maybe you can comment a little bit on how the front end of your business looks today versus maybe how it looked a year or two ago. I mean, I know you, guys, with an engineering background had a bit more focus on driving the front end and the sales channel more recently. So, how does that look today? How do you feel about that now versus maybe when you stepped into the role?

I feel really good about what's happening on the front end of our business. And we wanted to make our customer-facing capability as really as strong as our operational and engineering capability. And we're using some tools. I talked about that growth kaizens in the prior call where we're getting after ways to improve our distribution channel in our niche markets. We have a focus on digital marketing now to take some of our businesses that are truly world-class and bring all of them up to that level. We have a program on sales force effectiveness that involves the leadership development and compensation of our sales force. We're focusing on the aftermarket side of our business. We think there's opportunities to grow there. So, I'm very pleased with what's happening in the front end of our business and the focus on improving organic growth. Joseph Giordano - Cowen & Co. LLC: Thanks, Dave.

Thank you.

And our next question comes from the line of Rob Mason with Baird. Your line is now open. Rob W. Mason - Robert W. Baird & Co., Inc.: Yes, good morning. The prior commentary, you talked about or at least referenced broad-based growth globally, geographically. So, I was just curious if you could drill down into that how the various geographies look, and specifically, I know North America, it kind of lag Asia, Europe through the first half of the year. And specifically, maybe give some color on North America and which businesses you're seeing gain some strength there, because seemingly that's the case.

Yeah. That's an excellent point, because what we really saw this quarter was tremendous strength in the U.S. Our U.S. business was up high-single digits, and it was improving sequential trend from about, I think it was low-single-digit, 1% actually last quarter. So, we saw a tremendous strength in the U.S. and it was broad-based strength. It was a military business. It was our aerospace business. It was our metals business, it was oil and gas. It was really strong. It was across the board. So, we're very pleased to see that. In Europe, we were up mid-single digits, in line with recent trends. That was also broad based, and notable strength. I mentioned our Dunkermotoren business was very strong in Europe. Our process business was very strong in Europe. And in Asia, we had another great quarter, up high-single digits, continuing the growth that we've been seeing. So, across the geographies, we're very pleased with what we're seeing. Rob W. Mason - Robert W. Baird & Co., Inc.: Okay. And so, just one follow-up. So, it has been good to see the outlook ratchet up as we've gone through the year and I think you made reference to higher compensation as well. Any way to size what that year-over-year delta is going to probably shake out for 2017 in compensation or as a margin headwind year-over-year?

Yeah. I mean, our G&A in Q3 was up about 20%, and it was largely driven by higher compensation expense. So, that would be the best way to-Bill?

It's a $10 million kind of number for that. Rob W. Mason - Robert W. Baird & Co., Inc.: For the full year?

For the full year. Rob W. Mason - Robert W. Baird & Co., Inc.: Okay. Thank you.

And I'm showing no further questions at this time. So, with that, I'd like to turn the call back over to Kevin Coleman for closing remarks.

Great. Thank you, Andrew. And thank you, everyone, for joining us today. And as a reminder, a replay of today's call can be accessed in the Investors section of ametek.com. Thank you and have a great day.

Ladies and gentlemen, thank you for participating in today's conference. This does conclude the program. You may all disconnect. Everyone, have a wonderful day.